Your browser doesn't support javascript.
loading
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Gansane, Adama; Lingani, Moussa; Yeka, Adoke; Nahum, Alain; Bouyou-Akotet, Marielle; Mombo-Ngoma, Ghyslain; Kaguthi, Grace; Barceló, Catalina; Laurijssens, Bart; Cantalloube, Cathy; Macintyre, Fiona; Djeriou, Elhadj; Jessel, Andreas; Bejuit, Raphaël; Demarest, Helen; Marrast, Anne Claire; Debe, Siaka; Tinto, Halidou; Kibuuka, Afizi; Nahum, Diolinda; Mawili-Mboumba, Denise Patricia; Zoleko-Manego, Rella; Mugenya, Irene; Olewe, Frederick; Duparc, Stephan; Ogutu, Bernhards.
Afiliación
  • Gansane A; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), 01 BP 220801 BP 2208, Ouagadougou, Burkina Faso. agansane.cnrfp@fasonet.bf.
  • Lingani M; Institut de Recherche en Science de la Santé - Unité de Recherche Clinique de Nanoro (IRSS-URCN), Ouagadougou, Burkina Faso.
  • Yeka A; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
  • Nahum A; Centre de Recherches Entomologique de Cotonou (CREC), Cotonou, Benin.
  • Bouyou-Akotet M; Département de Parasitologie-Mycologie-Médecine Tropicale, Faculté de Médecine - Université des Sciences de la Santé, Libreville, Gabon.
  • Mombo-Ngoma G; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Kaguthi G; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Barceló C; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
  • Laurijssens B; Kenya Medical Research Institute-Centre for Respiratory Diseases Research (KEMRI-CRDR), Nairobi, Kenya.
  • Cantalloube C; Medicines for Malaria Venture, Geneva, Switzerland.
  • Macintyre F; BEL Pharm Consulting, Chambonas, France.
  • Djeriou E; Sanofi Research and Development, Chilly Mazarin, France.
  • Jessel A; Medicines for Malaria Venture, Geneva, Switzerland.
  • Bejuit R; Sanofi Research and Development, Chilly Mazarin, France.
  • Demarest H; Sanofi Research and Development, Bridgewater, NJ, USA.
  • Marrast AC; Sanofi Research and Development, Chilly Mazarin, France.
  • Debe S; Medicines for Malaria Venture, Geneva, Switzerland.
  • Tinto H; Medicines for Malaria Venture, Geneva, Switzerland.
  • Kibuuka A; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), 01 BP 220801 BP 2208, Ouagadougou, Burkina Faso.
  • Nahum D; Institut de Recherche en Science de la Santé - Unité de Recherche Clinique de Nanoro (IRSS-URCN), Ouagadougou, Burkina Faso.
  • Mawili-Mboumba DP; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
  • Zoleko-Manego R; Centre de Recherches Entomologique de Cotonou (CREC), Cotonou, Benin.
  • Mugenya I; Département de Parasitologie-Mycologie-Médecine Tropicale, Faculté de Médecine - Université des Sciences de la Santé, Libreville, Gabon.
  • Olewe F; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Duparc S; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ogutu B; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Malar J ; 22(1): 2, 2023 Jan 03.
Article en En | MEDLINE | ID: mdl-36597076

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Antimaláricos Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2023 Tipo del documento: Article País de afiliación: Burquina Faso

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Antimaláricos Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2023 Tipo del documento: Article País de afiliación: Burquina Faso